EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE | A220232 | LAURUS LABS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY et al v. LAURUS LABS, LTD. et al 3 patentsANDA 220232emtricitabine, rilpivirine, and tenofovir disoproxil fumarate | D.N.J. | 2025-03-24 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.